Newsletters

Global Life Science Business Partnering (GLSBP) - March 2022

Highlights of March 2022Aurobindo Pharma acquires Veritaz formulation biz for Rs 171 crores (~US$23M).Alembic Pharma acquires 100% stake in Aleor...

Read More

Global Life Science Business Partnering (GLSBP) - February 2022

Highlights of February 2022Glenmark Pharmaceuticals enters into licensing agreement with AstraZeneca Colombia for the commercialization of AstraZ...

Read More

Global Life Science Business Partnering (GLSBP) - January 2022

Highlights of January 2022Lupin Pharmaceuticals and Exeltis USA announced a promotional agreement for Exeltis to promote SOLOSEC along with Exelt...

Read More

December 2021 - Global Life Science Business Partnering - News & Updates

Highlights of December 2021 Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio. ...

Read More

November 2021- Global Life Science Business Partnering - News & Updates

Highlights of November 2021 1.            ...

Read More

October 2021- Global Life Science Business Partnering - News & Updates

Highlights of October 2021Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly key diabetes products.Exelixis...

Read More

September 2021- Global Life Science Business Partnering - News & Updates

Highlights of September 2021Zydus Cadila inks deal with Shilpa Medicare for ZyCoV-D COVID-19 vaccine production.Serum Life Sciences to invest £5...

Read More

August 2021- Global Life Science Business Partnering - News & Updates

Highlights of August 2021Serum Institute of India acquires 50% stake of SCHOTT Kaisha.Mylab, Hemex Health ink tech partnership for PoC diagnostic...

Read More

July 2021- Global Life Science Business Partnering - News & Updates

Highlights of July 2021Sun Pharma signs agreement with Cassiopea for acne drug in US and Canada.Lupin to Acquire Australian Pharma Company Southe...

Read More

June 2021- Global Life Science Business Partnering - News & Updates

Highlights of June 2021 Quadria Capital to buy 15% stake in Encube Ethicals valuing firm at US$800 Million. Ocugen pays US$15 million ...

Read More

×
Twitter